Hospitalization costs for heart failure in people with type 2 diabetes: Cost-effectiveness of its prevention measured by a simulated preventive treatment

Value in Health

Volumn 14, Issue 5 SUPPL., 2011, Pages

  Caporale, Joaquín E ^a   Elgart, Jorge ^a   Pfirter, Guillermina ^a   Martínez, Pablo ^b   Vies, Gloria ^b   Insa, Jorge T ^c   Gagliardino, Juan J ^a  

^a University of La Plata CONICET   (Argentina)

^b HOSPITAL PRIVADO DE COMUNIDAD   (Argentina)

^c UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

cost analysis; diabetes; heart failure; prevention and control

Indexed keywords

GLIBENCLAMIDE; HEMOGLOBIN A1C; INSULIN; METFORMIN;

AGED; ARGENTINA; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; FEMALE; HEART FAILURE; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MONEY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTOR VARIABLE; PRIORITY JOURNAL; SIMULATION; CONFERENCE PAPER; DIABETIC PATIENT; MONTE CARLO METHOD; PREVENTIVE MEDICINE; RISK REDUCTION; SENSITIVITY ANALYSIS;

AGED; AGED, 80 AND OVER; ARGENTINA; BIOLOGICAL MARKERS; COMPUTER SIMULATION; COST SAVINGS; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; DRUG COSTS; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MODELS, ECONOMIC; MONTE CARLO METHOD; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT READMISSION; PREVENTIVE HEALTH SERVICES; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052636834     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.05.018     Document Type: Article

References (20)

1. T.B. Horwich, and G.C. Fonarow Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure J Am Coll Cardiol 55 2010 283 293
2. D. Lloyd-Jones, R. Adams, and M. Carnethon Heart disease and stroke statistics2009 update A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 e21 e181
3. J. Fang, G.A. Mensah, J.B. Croft, and N.L. Keenan Heart failure-related hospitalization in the U.S., 1979 to 2004 J Am Coll Cardiol 52 2008 428 434 (Pubitemid 352040814)
4. W.B. Kannel, M. Hjortland, and W.P. Castelli Role of diabetes in congestive heart failure: the Framingham study Am J Cardiol 34 1974 29 34
5. G.A. Nichols, C.M. Gullion, and C.E. Koro The incidence of congestive heart failure in type 2 diabetes: an update Diabetes Care 27 2004 1879 1884 (Pubitemid 38989226)
6. K. Bibbins-Domingo, F. Lin, and E. Vittinghoff Predictors of heart failure among women with coronary disease Circulation 110 2004 1424 1430 (Pubitemid 39263737)
7. C. Iribarren, A.J. Karter, and A.S. Go Glycemic control and heart failure among adult patients with diabetes Circulation 103 2001 2668 2673 (Pubitemid 32538780)
8. I.M. Stratton, A.I. Adler, and H.A.W. Neil Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 2000 405 412 (Pubitemid 30609442)
9. A. Pazin-Filho, A. Kottgen, and A.G. Bertoni HbA1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study Diabetologia 51 2008 2197 2204
10. J.C. Chan, J.J. Gagliardino, S.H. Baik The IDMPS Investigators Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS) Diabetes Care 32 2009 227 233
11. J.J. Gagliardino, M. de la Hera, F. Siri Grupo de Investigación de la Red QUALIDIAB Evaluación de la calidad de la asistencia al paciente diabético en América Latina Rev Panam Salud Pública 10 2001 309 317 (Pubitemid 33143953)
12. American Diabetes Association clinical practice recommendations Diabetes Care 25 Suppl. 2002 S1 S147
13. R.C. Turner, C.C. Frighi, and R.R. Holman Glycemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49) JAMA 281 1999 2005 2012 (Pubitemid 29254858)
14. E. Mueller, S. Maxion-Bergemann, and D. Gultyaev Development and validation of the Economic Assessment of Glycemic Control and Long-Term Effects of Diabetes (EAGLE) model Diabetes Technol Ther 8 2006 219 236 (Pubitemid 43848043)
15. A.A. Carr, P.R. Kowey, and R.B. Devereux Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies Am J Cardiol 96 2005 1530 1536 (Pubitemid 41690173)
16. A.A. Tahrani, G.I. Varughese, J.H. Scarpello, and F.W.F. Hanna Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? BMJ 335 2007 508 512 (Pubitemid 47401613)
17. A. Karter, M. Stevens, and W.H. Herman Out-of-pocket costs and diabetes prevention services: the Translating Research Into Action for Diabetes (TRIAD) study Diabetes Care 26 2003 2294 2299 (Pubitemid 36993315)
18. Primera Encuesta Nacional de Factores de Riesgo Ministerio de Salud de la Nación http://www.msal.gov.ar/htm/Site/enfr/index.asp [Accessed June 23, 2006]
19. A.W. Haider, M.G. Larson, S.S. Franklin, and D. Levy Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study Ann Intern Med 138 2003 10 16 (Pubitemid 36232089)
20. P.M. Clarke, A.M. Gray, and A. Briggs A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) outcomes model (UKPDS 68) Diabetologia 47 2004 1747 1759 (Pubitemid 40022410)